Fortis Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Fortis Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $126,318 - $228,752	-1,850 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $4,626 - $7,875	73 Added 4.11%	1,850 $135,000
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $153,266 - $213,524	1,777 New	1,777 $177,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.